Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease.

Harmful alcohol use and alcohol use disorder (AUD) are common worldwide, and rates of alcohol-associated liver disease (ALD) are also increasing. AUD is a disease that is treatable and can be diagnosed and managed, and recovery from AUD through abstinence or reductions in drinking is possible. Management of AUD among individuals with ALD is increasingly being addressed via integrated medical and psychosocial treatment teams that can support reductions in drinking and prevent progression of liver disease. Early diagnosis of AUD and ALD can improve lives and reduce mortality.
Competing Interests: Disclosure K. Witkiewitz has received travel and speaker fees in the past 5 years from the Alcohol Clinical Trials Initiative (ACTIVE) Workgroup which has been supported previously, but not in the past 36 months, by Abbott/Abbvie, Amygdala Neurosciences, Arbor Pharmaceuticals, GSK, Janssen, Lilly, Mitsubishi, Pfizer, and Schering Plow, but in the past 36 months its activities were supported by Alkermes, Dicerna, Ethypharm, Indivior, Kinnov Therapeutics, Lundbeck, Otsuka, and Pear Therapeutics. J.L. Mellinger has consulted for GlaxoSmithKline. This research was supported by R01AA022328 (PI WItkiewitz) from the National Institute on Alcohol Abuse and Alcoholism.
(Copyright © 2024 Elsevier Inc. All rights reserved.)